Australian drug regulator requires warning on Zolpidem
Friday, February 22, 2008 Australia’s Therapeutic Goods Administration (TDC) will require makers of the sleeping pill, Zolpidem (marketed as Stilnox in Australia) to provide a warning about its “bizarre” and “potentially dangerous” side effects. The warning follows a decision by the National Drugs and Poisons Schedule Committee (NDPSC) not to …